NanoCarrier Co., Ltd. (4571.T)
JPY 150.0
(-1.96%)
JPY 150.0
(-1.96%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -780 Million JPY | 40.5% |
| 2022 | -1.31 Billion JPY | 30.33% |
| 2021 | -1.88 Billion JPY | 33.65% |
| 2020 | -2.83 Billion JPY | -41.11% |
| 2019 | -2 Billion JPY | -11.12% |
| 2018 | -1.8 Billion JPY | 66.61% |
| 2017 | -5.41 Billion JPY | -102.42% |
| 2016 | -2.67 Billion JPY | -5.47% |
| 2015 | -2.53 Billion JPY | -1124.75% |
| 2014 | -207.15 Million JPY | 81.4% |
| 2013 | -1.11 Billion JPY | -129.89% |
| 2012 | -484.44 Million JPY | -21.72% |
| 2011 | -398 Million JPY | 28.31% |
| 2010 | -555.17 Million JPY | -12.2% |
| 2009 | -494.79 Million JPY | 5.66% |
| 2008 | -524.48 Million JPY | -6.16% |
| 2007 | -494.03 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -156 Million JPY | -266.66% |
| 2023 Q3 | -260.09 Million JPY | -35.76% |
| 2023 Q4 | -42.54 Million JPY | 83.64% |
| 2023 Q1 | -285.77 Million JPY | 8.31% |
| 2023 Q2 | -191.58 Million JPY | 32.96% |
| 2023 FY | -780 Million JPY | 40.5% |
| 2022 Q1 | -327.96 Million JPY | 30.08% |
| 2022 Q4 | -311.68 Million JPY | -177.58% |
| 2022 FY | -1.31 Billion JPY | 30.33% |
| 2022 Q2 | -559.03 Million JPY | -70.46% |
| 2022 Q3 | -112.28 Million JPY | 79.91% |
| 2021 Q3 | -437.34 Million JPY | 14.36% |
| 2021 Q4 | -469.03 Million JPY | -7.25% |
| 2021 Q2 | -510.69 Million JPY | -9.92% |
| 2021 Q1 | -464.59 Million JPY | -20.63% |
| 2021 FY | -1.88 Billion JPY | 33.65% |
| 2020 FY | -2.83 Billion JPY | -41.11% |
| 2020 Q2 | -1.86 Billion JPY | -752.06% |
| 2020 Q3 | -368.51 Million JPY | 80.22% |
| 2020 Q4 | -385.14 Million JPY | -4.51% |
| 2020 Q1 | -218.69 Million JPY | 74.94% |
| 2019 Q1 | -446.49 Million JPY | -28.18% |
| 2019 Q4 | -872.55 Million JPY | -262.8% |
| 2019 FY | -2 Billion JPY | -11.12% |
| 2019 Q2 | -450.11 Million JPY | -0.81% |
| 2019 Q3 | -240.5 Million JPY | 46.57% |
| 2018 FY | -1.8 Billion JPY | 66.61% |
| 2018 Q4 | -348.33 Million JPY | 36.72% |
| 2018 Q3 | -550.44 Million JPY | -101.53% |
| 2018 Q1 | -636.6 Million JPY | 18.91% |
| 2018 Q2 | -273.13 Million JPY | 57.1% |
| 2017 Q3 | -2.58 Billion JPY | -226.96% |
| 2017 Q1 | -1.25 Billion JPY | -36.96% |
| 2017 FY | -5.41 Billion JPY | -102.42% |
| 2017 Q4 | -785.01 Million JPY | 69.6% |
| 2017 Q2 | -789.82 Million JPY | 37.29% |
| 2016 Q2 | -724.27 Million JPY | 30.87% |
| 2016 Q1 | -1.04 Billion JPY | 9.97% |
| 2016 Q4 | -919.63 Million JPY | -6017.83% |
| 2016 Q3 | 15.54 Million JPY | 102.15% |
| 2016 FY | -2.67 Billion JPY | -5.47% |
| 2015 Q3 | -467.35 Million JPY | 22.03% |
| 2015 Q1 | -306.67 Million JPY | -25.78% |
| 2015 Q4 | -1.16 Billion JPY | -149.01% |
| 2015 Q2 | -599.38 Million JPY | -95.45% |
| 2015 FY | -2.53 Billion JPY | -1124.75% |
| 2014 Q1 | -461.84 Million JPY | 3.62% |
| 2014 FY | -207.15 Million JPY | 81.4% |
| 2014 Q4 | -243.81 Million JPY | -229.51% |
| 2014 Q3 | 188.25 Million JPY | -39.32% |
| 2014 Q2 | 310.25 Million JPY | 167.18% |
| 2013 FY | -1.11 Billion JPY | -129.89% |
| 2013 Q2 | -246.33 Million JPY | -28.94% |
| 2013 Q3 | -197.13 Million JPY | 19.97% |
| 2013 Q4 | -479.17 Million JPY | -143.07% |
| 2013 Q1 | -191.04 Million JPY | -48.93% |
| 2012 FY | -484.44 Million JPY | -21.72% |
| 2012 Q3 | -88.1 Million JPY | -0.06% |
| 2012 Q2 | -88.04 Million JPY | 51.09% |
| 2012 Q4 | -128.27 Million JPY | -45.6% |
| 2012 Q1 | -180.02 Million JPY | -64.86% |
| 2011 Q4 | -109.19 Million JPY | 38.65% |
| 2011 Q1 | -155 Million JPY | -7.64% |
| 2011 FY | -398 Million JPY | 28.31% |
| 2011 Q3 | -177.99 Million JPY | -502.8% |
| 2011 Q2 | 44.19 Million JPY | 128.51% |
| 2010 Q1 | -145.69 Million JPY | -19.31% |
| 2010 Q4 | -144 Million JPY | -18.27% |
| 2010 Q3 | -121.75 Million JPY | 15.29% |
| 2010 Q2 | -143.73 Million JPY | 1.35% |
| 2010 FY | -555.17 Million JPY | -12.2% |
| 2009 Q2 | -126.4 Million JPY | 19.86% |
| 2009 Q3 | -88.54 Million JPY | 29.95% |
| 2009 FY | -494.79 Million JPY | 5.66% |
| 2009 Q4 | -122.11 Million JPY | -37.91% |
| 2009 Q1 | -157.72 Million JPY | -77.75% |
| 2008 Q3 | -146.1 Million JPY | 0.0% |
| 2008 Q4 | -88.73 Million JPY | 39.27% |
| 2008 FY | -524.48 Million JPY | -6.16% |
| 2007 FY | -494.03 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 303.126% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -48.032% |
| GNI Group Ltd. | 8.09 Billion JPY | 109.637% |
| Linical Co., Ltd. | 338.26 Million JPY | 330.588% |
| Trans Genic Inc. | 4.08 Million JPY | 19194.296% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 45.756% |
| Soiken Holdings Inc. | -662.2 Million JPY | -17.789% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 664.585% |
| AnGes, Inc. | -7.43 Billion JPY | 89.513% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 39.447% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 89.156% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 517.797% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 32.344% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 35.484% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | 3.989% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -140.993% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 36.066% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 45.151% |
| PeptiDream Inc. | 3.03 Billion JPY | 125.693% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 59.763% |
| Ribomic Inc. | -1.02 Billion JPY | 23.846% |
| SanBio Company Limited | -2.64 Billion JPY | 70.499% |
| Healios K.K. | -3.82 Billion JPY | 79.597% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 33.224% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 47.637% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 45.431% |
| StemRIM | -2.02 Billion JPY | 61.424% |
| CellSource Co., Ltd. | 923.14 Million JPY | 184.494% |
| FunPep Company Limited | -933.41 Million JPY | 16.436% |
| Kringle Pharma, Inc. | -854.15 Million JPY | 8.681% |
| Stella Pharma Corporation | -763.74 Million JPY | -2.128% |
| TMS Co., Ltd. | -960.04 Million JPY | 18.753% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 30.974% |
| Cuorips Inc. | -632.18 Million JPY | -23.382% |
| K Pharma,Inc. | 260.33 Million JPY | 399.62% |
| Takara Bio Inc. | 1.48 Billion JPY | 152.703% |
| ReproCELL Incorporated | -31.41 Million JPY | -2382.897% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 3057.017% |
| StemCell Institute Inc. | 310.98 Million JPY | 350.82% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 644.812% |
| CellSeed Inc. | -846.53 Million JPY | 7.859% |